Double your impact Match My Donation

Alexandra Mulvey

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer

November 9, 2018Arthur N. Brodsky, Ph.D.
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1 immunotherapy for treatment.

Read More

Filter by:

*Immunotherapy results may vary from patient to patient.